Forward equity raise targets up to $250 million, but delays cash and adds dilution

This is a material future equity raise, not immediate funding. The offering covers 12.65 million shares after the underwriters fully exercised the 1.65 million-share option, but BNL says it will initially receive no proceeds because the shares were sold by the forward sellers. Cash is expected only when BNL physically settles the forward contracts by September 30, 2027, at the earliest. (Item 8.01 — Offering and Forward Sale Agreements)

| Base shares offered | 11.00 million (Item 8.01 — Offering)

| Additional shares | 1.65 million (Item 8.01 — Offering)

| Total potential shares | 12.65 million (Item 8.01 — Forward Sale Agreements)

| Public offering price | $20.50 per share (Item 8.01 — Offering)

| Initial forward sale price | $19.7825 per share (Item 8.01 — Forward Sale Agreements)

| Forward settlement deadline | September 30, 2027 (Item 8.01 — Forward Sale Agreements)

The economics are modestly less favorable than the headline offering price suggests. The effective initial forward price of $19.7825 is $0.7175 below the $20.50 public offering price, or roughly a 3.5% discount. BNL also accepts future dilution without receiving cash today; the final proceeds and share count can change through contractual adjustments or cash/net-share settlement. (Item 8.01 — Forward Sale Agreements)

The filing provides no announced acquisition, investment target, or other use of proceeds to offset the dilution. That leaves the immediate read centered on balance-sheet flexibility rather than demonstrated growth: BNL has secured a financing channel for up to roughly $250 million, but the filing does not show what those funds will earn or why the timing is attractive. (Item 8.01 — Offering and Forward Sale Agreements)

Against expectations, the signal is mixed rather than a clean beat or miss. No published operating consensus or prior financing target is provided in the filing, so there is no substantiated earnings-style comparison. The transaction improves future access to capital, but its delayed funding, discounted forward price, and eventual share issuance create a clear dilution cost; the net effect depends on how productively BNL deploys the proceeds.